AKBULUT, H. Et Al. 2018. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.. ASCO 2018 .

AKBULUT, H., Öçal, M., Sonugür, F. G., Babahan, C., & Abdi Abgarmi, S., (2018). The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study. . ASCO 2018

AKBULUT, HAKAN Et Al. "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.," ASCO 2018, 2018

AKBULUT, HAKAN Et Al. "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.." ASCO 2018 , 2018

AKBULUT, H. Et Al. (2018) . "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.." ASCO 2018 .

@conferencepaper{conferencepaper, author={HAKAN AKBULUT Et Al. }, title={The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.}, congress name={ASCO 2018}, city={}, country={}, year={2018}}